Monthly Archives: September 2013

Pregnant Kate Winslet Talks Chemistry With Josh Brolin at Labor Day Premiere | POPSUGAR Interview – Video

Posted on by


Pregnant Kate Winslet Talks Chemistry With Josh Brolin at Labor Day Premiere | POPSUGAR Interview
Kate Winslet and Josh Brolin star in the upcoming Jason Reitman film Labor Day and joined forces to debut the movie at the Toronto International Film Festiva...

By: POPSUGAR Entertainment

See the article here:
Pregnant Kate Winslet Talks Chemistry With Josh Brolin at Labor Day Premiere | POPSUGAR Interview - Video

Environmental Biotechnology and Global Water Sustainability | MconneX | Lecture On-Demand – Video

Posted on by


Environmental Biotechnology and Global Water Sustainability | MconneX | Lecture On-Demand
Optimizing Biofiltration for Drinking Water Treatment - the Role of Microbial Ecology Lutgarde Raskin, Professor of Environmental Engineering Civil and Envir...

By: michiganengineering

Read the original post:
Environmental Biotechnology and Global Water Sustainability | MconneX | Lecture On-Demand - Video

General, Organic and Biochemistry 8th Edition (International Edition) – A Quick Review – Video

Posted on by


General, Organic and Biochemistry 8th Edition (International Edition) - A Quick Review
This is a review of the International Edition of General, Organic and Biochemistry 8th Edition, by Katherine Denniston, Joseph Topping, Kim Woodrum and Rober...

By: 123457474869

Read the original post:
General, Organic and Biochemistry 8th Edition (International Edition) - A Quick Review - Video

Former Grey’s Anatomy Star Katherine Heigl to Front New NBC Spy Drama – Video

Posted on by


Former Grey #39;s Anatomy Star Katherine Heigl to Front New NBC Spy Drama
http://www.celebified.com - Get the hottest scoop on your favorite stars, TV shows, movies, and more! http://www.facebook.com/Celebified - #39;Like #39; us and join...

By: Celebified

Read more from the original source:
Former Grey's Anatomy Star Katherine Heigl to Front New NBC Spy Drama - Video

Cichon Named Professor in Loyola Department of Cell and Molecular Physiology

Posted on by

Newswise Mark Cichon, DO, professor and chairman of the Department of Emergency Medicine was awarded a joint appointment as professor in the Department of Cell and Molecular Physiology at Loyola University Stritch School of Medicine.

Dr. Cichons joint appointment is a testament to the breadth of his knowledge and expertise, said Richard M. Gamelli, MD, FACS, senior vice president and provost of health sciences at Loyola. We look forward to Dr.Cichons continued success in teaching and research at Loyola.

A native of Chicago, Cichon did his undergraduate studies at Loyola University Chicago graduating with a bachelor of science degree in biology. He earned his Doctor of Osteopathic Medicine degree at Chicago College of Osteopathic Medicine - Midwestern University.

After completing a residency in Emergency Medicine and obtaining his Emergency Medicine Board Certification, Cichon has been a practicing clinician in several hospitals in the Chicago and suburban area.For nearly two decades, Cichon has served as Director of Emergency Medical Services at Loyola University Medical Center in Maywood.

At Loyola, Cichon is responsible for the medical care and direction of the paramedic (pre-hospital) program, the emergency department, the LIFESTAR flight program, the Emergency Medical Services for Children Grant in Illinois, and the regional disaster preparedness program for the Illinois Department of Public Health.

Cichon has published articles pertaining to pre-hospital care, pediatric emergency care, and in his research interests pertaining to biomarker use for the early detection of cardiac injury and developing sepsis.

Cichon serves on the board of the Illinois College of Emergency Physicians (ICEP) as well as additional national, state and local committees in his fields of interest and in community interests.

See the article here:
Cichon Named Professor in Loyola Department of Cell and Molecular Physiology

UTHSC strikes licensing deal

Posted on by

The University of Texas Health Science Center and the Southwest Research Institute have licensed new uses for a drug that has shown it can slow the aging process to a San Antonio startup biotechnology company.

The company, Rapamycin Holdings Inc., takes its name from the drug rapamycin, which has long been federally approved to suppress organ rejection in transplant recipients.

Rapamycin Holdings hopes to one day commercialize the drug for anti-aging purposes.

Instead of accepting physical and cognitive decline, we're looking for answers and solutions, said Rapamycin Holdings CEO George Fillis. Hopefully, the answer will be to extend healthy human life.

Terms of the licensing agreement were not disclosed.

So far, Rapamycin Holdings has raised an undisclosed amount in seed funding to conduct a series of analytical tests to determine how the drug performs on a therapeutic level in the bloodstream, Fillis said.

The Texas Technology Development Center, or T3DC, and the Texas Research & Technology Foundation, are among the organizations that provided investment capital to the company.

Rapamycin Holdings plans to raise an additional $6 million once it nears Phase 1 clinical trials for its first drug product.

Z. Dave Sharp, a professor of molecular medicine at the health science center, in 2004 conceived the project to slow the aging process.

The federal government later awarded about $5 million in stimulus money to the health science center to study rapamycin and its anti-aging effects in mice.

Continued here:
UTHSC strikes licensing deal

The Arrow Group of Animal Hospitals in Central Arizona Partners with Vet-Stem, Inc. to Bring Stem Cell Therapy to …

Posted on by

Poway, California (PRWEB) September 12, 2013

The Arrow Group of Animal Hospitals, out of Glendale, Arizona and their 17 Phoenix Metro area veterinary hospitals have partnered with California based Vet-Stem, Inc., the leading Regenerative Veterinary Medicine company, to bring stem cell therapy to their patients. Dogs that are suffering pain or inflammation from osteoarthritis or polyarthritis, joint or ligament issues, or muscle injuries, can now receive stem cell therapy.

The Arrow Group of Animal Hospitals hosted Vet-Stems Corey Orava, DVM for a week of training sessions to help all of their staff learn the ins and outs of stem cell therapy. Veterinarians and technicians benefited from hands-on labs and a continuing education course that will help them bring the best care to their patients and pet owners. Under the mentorship of Dr. Orava Dobson Ranch Animal Hospital, Fletcher Heights Animal Hospital, Surprise Animal Hospital and Animal Hospital at Anthem were able to perform their debut stem cell therapy cases during their initial week of offering the new service.

The Arrow Group of Animal Hospitals is a co-operative group of 17 individual small animal hospitals around the valley that are proud to offer the highest quality veterinary care possible. The doctors and staff at each hospital strive to build a long term relationship with their client families and their pets, always making recommendations in the pets best health interest. The Arrow Group of Animal Hospitals offer complete veterinary care from wellness, to vaccines, spays and neuters, dental, surgical and now regenerative medicine. Their animal hospital locations can be easily found at http://www.azpetvet.com.

About Vet-Stem, Inc. Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. The privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, Vet-Stem, Inc. pioneered the use of regenerative stem cells in veterinary medicine. The company holds exclusive licenses to over 50 patents including world-wide veterinary rights for use of adipose derived stem cells. In the last decade over 10,000 animals have been treated using Vet-Stem, Inc.s services, and Vet-Stem is actively investigating stem cell therapy for immune-mediated and inflammatory disease, as well as organ disease and failure. For more on Vet-Stem, Inc. and Veterinary Regenerative Medicine visit http://www.vet-stem.com or call 858-748-2004.

See original here:

The Arrow Group of Animal Hospitals in Central Arizona Partners with Vet-Stem, Inc. to Bring Stem Cell Therapy to ...